Similarly, the improved survival after treatment of melanoma patients with CTLA-4 blocking antibodies (84) may also involve Cbl-b down-regulation as activation of CTLA-4 increases Cbl-b levels by transcriptional regulation (Figure 2) (40). Here, CTLA4 is linked to melanoma.